Skip to main content
. 2020 Sep 16;3(9):e2013196. doi: 10.1001/jamanetworkopen.2020.13196

Figure 2. Improvement in Pain Severity, C-Reactive Protein Level, and Erythrocyte Sedimentation Rate for Placebo Arms of Trials 1 Through 4 .

Figure 2.

Values are means for pain (measured by a visual analog scale with values 0-100 mm) (A) and geometric means for C-reactive protein level (B) and erythrocyte sedimentation rate (C) to account for log-normal distribution. All mean changes were significant (P < .001).